AstraZeneca's U.S. tweeters -- @AstraZenecaUS -- recently told their 4,134 followers that the company had received a "Community Partner of the Year," award, for example. It ignored news that the company's most important new drug, the blood thinner Brilinta, had failed to win regulatory approval.
Sunday, December 19, 2010
Big Pharma's small voice | delawareonline.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment